Neuroprotection by Acetyl-L-Carnitine after Traumatic Injury to the Immature Rat Brain

Traumatic brain injury (TBI) is the leading cause of mortality and morbidity in children and is characterized by reduced aerobic cerebral energy metabolism early after injury, possibly due to impaired activity of the pyruvate dehydrogenase complex. Exogenous acetyl-L-carnitine (ALCAR) is metabolized in the brain to acetyl coenzyme A and subsequently enters the tricarboxylic acid cycle. ALCAR administration is neuroprotective in animal models of cerebral ischemia and spinal cord injury, but has not been tested for TBI. This study tested the hypothesis that treatment with ALCAR during the first 24 h following TBI in immature rats improves neurologic outcome and reduces cortical lesion volume. Postnatal day 21–22 male rats were isoflurane anesthetized and used in a controlled cortical impact model of TBI to the left parietal cortex. At 1, 4, 12 and 23 h after injury, rats received ALCAR (100 mg/kg, intraperitoneally) or drug vehicle (normal saline). On days 3–7 after surgery, behavior was assessed using beam walking and novel object recognition tests. On day 7, rats were transcardially perfused and brains were harvested for histological assessment of cortical lesion volume, using stereology. Injured animals displayed a significant increase in foot slips compared to sham-operated rats (6 ± 1 SEM vs. 2 ± 0.2 on day 3 after trauma; n = 7; p < 0.05). The ALCAR-treated rats were not different from shams and had fewer foot slips compared to vehicle-treated animals (2 ± 0.4; n = 7; p< 0.05). The frequency of investigating a novel object for saline-treated TBI animals was reduced compared to shams (45 ± 5% vs. 65 ± 10%; n = 7; p < 0.05), whereas the frequency of investigation for TBI rats treated with ALCAR was not significantly different from that of shams but significantly higher than that of saline-treated TBI rats (68 ± 7; p < 0.05). The left parietal cortical lesion volume, expressed as a percentage of the volume of tissue in the right hemisphere, was significantly smaller in ALCAR-treated than in vehicle-treated TBI rats (14 ± 5% vs. 28 ± 6%; p < 0.05). We conclude that treatment with ALCAR during the first 24 h after TBI improves behavioral outcomes and reduces brain lesion volume in immature rats within the first 7 days after injury.

[1]  A. Ennaceur One-trial object recognition in rats and mice: Methodological and theoretical issues , 2010, Behavioural Brain Research.

[2]  G. Fiskum,et al.  Metabolism of acetyl‐l‐carnitine for energy and neurotransmitter synthesis in the immature rat brain , 2010, Journal of neurochemistry.

[3]  E. Hall,et al.  Lipid peroxidation-derived reactive aldehydes directly and differentially impair spinal cord and brain mitochondrial function. , 2010, Journal of neurotrauma.

[4]  T. Maher,et al.  Acetyl‐l‐carnitine reduces the infarct size and striatal glutamate outflow following focal cerebral ischemia in rats , 2010, Annals of the New York Academy of Sciences.

[5]  Alexander Sasha Rabchevsky,et al.  Acetyl‐l‐carnitine ameliorates mitochondrial dysfunction following contusion spinal cord injury , 2010, Journal of neurochemistry.

[6]  D. McArthur,et al.  Early Nonischemic Oxidative Metabolic Dysfunction Leads to Chronic Brain Atrophy in Traumatic Brain Injury , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[7]  D. Hovda,et al.  Ontogeny of Rat Recognition Memory measured by the novel object recognition task. , 2009, Developmental psychobiology.

[8]  G. Fiskum,et al.  Mitochondrial mechanisms of cell death and neuroprotection in pediatric ischemic and traumatic brain injury , 2009, Experimental Neurology.

[9]  H. Hagberg,et al.  Apoptotic Mechanisms in the Immature Brain: Involvement of Mitochondria , 2009, Journal of child neurology.

[10]  D. Prasad,et al.  Acetyl-l-carnitine (ALCAR) prevents hypobaric hypoxia–induced spatial memory impairment through extracellular related kinase–mediated nuclear factor erythroid 2-related factor 2 phosphorylation , 2009, Neuroscience.

[11]  G. Ling,et al.  Role of pyruvate dehydrogenase complex in traumatic brain injury and Measurement of pyruvate dehydrogenase enzyme by dipstick test , 2009, Journal of emergencies, trauma, and shock.

[12]  G. Fiskum,et al.  Delayed cerebral oxidative glucose metabolism after traumatic brain injury in young rats , 2009, Journal of neurochemistry.

[13]  W. Watson,et al.  Traumatic brain injury-induced expression and phosphorylation of pyruvate dehydrogenase: A mechanism of dysregulated glucose metabolism , 2009, Neuroscience Letters.

[14]  D. Hovda,et al.  The effects of a ketogenic diet on behavioral outcome after controlled cortical impact injury in the juvenile and adult rat. , 2009, Journal of neurotrauma.

[15]  Giovanni Pennisi,et al.  Cellular Stress Response: A Novel Target for Chemoprevention and Nutritional Neuroprotection in Aging, Neurodegenerative Disorders and Longevity , 2008, Neurochemical Research.

[16]  L. Packer,et al.  Protective effects of R‐alpha‐lipoic acid and acetyl‐L‐carnitine in MIN6 and isolated rat islet cells chronically exposed to oleic acid , 2008, Journal of cellular biochemistry.

[17]  E. Hall,et al.  Evolution of post-traumatic neurodegeneration after controlled cortical impact traumatic brain injury in mice and rats as assessed by the de Olmos silver and fluorojade staining methods. , 2008, Journal of neurotrauma.

[18]  M. Prins,et al.  Cerebral Metabolic Adaptation and Ketone Metabolism after Brain Injury , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[19]  R. Clark,et al.  Recognition memory and the medial temporal lobe: a new perspective , 2007, Nature Reviews Neuroscience.

[20]  O. Sakowitz,et al.  Heterogeneous regional and temporal energetic impairment following controlled cortical impact injury in rats , 2007, Neurological research.

[21]  G. Fiskum,et al.  Mitochondrial dysfunction early after traumatic brain injury in immature rats , 2007, Journal of neurochemistry.

[22]  Vidya N. Nukala,et al.  Proteomic identification of oxidized mitochondrial proteins following experimental traumatic brain injury. , 2007, Journal of neurotrauma.

[23]  M. Youle,et al.  A double‐blind, parallel‐group, placebo‐controlled, multicentre study of acetyl l‐carnitine in the symptomatic treatment of antiretroviral toxic neuropathy in patients with HIV‐1 infection , 2007, HIV medicine.

[24]  P. R. L. Vasconcelos,et al.  Ketone bodies metabolism during ischemic and reperfusion brain injuries following bilateral occlusion of common carotid arteries in rats. , 2007, Acta cirurgica brasileira.

[25]  M. Calvani,et al.  Protective effect of acetyl‐l‐carnitine against oxidative stress induced by antiretroviral drugs , 2006, FEBS letters.

[26]  G. Ling,et al.  Severity level and injury track determine outcome following a penetrating ballistic-like brain injury in the rat , 2006, Neuroscience Letters.

[27]  Rick A Bevins,et al.  Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study 'recognition memory' , 2006, Nature Protocols.

[28]  M. Sayed-Ahmed,et al.  CARNITINE ESTERS PREVENT OXIDATIVE STRESS DAMAGE AND ENERGY DEPLETION FOLLOWING TRANSIENT FOREBRAIN ISCHAEMIA IN THE RAT HIPPOCAMPUS , 2006, Clinical and experimental pharmacology & physiology.

[29]  P. Kochanek,et al.  Oxidative Stress in Immature Brain after Traumatic Brain Injury , 2006, Developmental Neuroscience.

[30]  R. Rosenthal,et al.  Postischemic hyperoxia reduces hippocampal pyruvate dehydrogenase activity. , 2006, Free radical biology & medicine.

[31]  D. Butterfield,et al.  Proteomics analyses of specific protein oxidation and protein expression in aged rat brain and its modulation by L-acetylcarnitine: insights into the mechanisms of action of this proposed therapeutic agent for CNS disorders associated with oxidative stress. , 2006, Antioxidants & redox signaling.

[32]  D. Hovda,et al.  Age‐dependent reduction of cortical contusion volume by ketones after traumatic brain injury , 2005, Journal of neuroscience research.

[33]  P. Hof,et al.  Normoxic Resuscitation after Cardiac Arrest Protects against Hippocampal Oxidative Stress, Metabolic Dysfunction, and Neuronal Death , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[34]  R. Rosenthal,et al.  Mechanisms of Ischemic Neuroprotection by Acetyl‐l‐carnitine , 2005, Annals of the New York Academy of Sciences.

[35]  Menotti Calvani,et al.  Acetylcarnitine induces heme oxygenase in rat astrocytes and protects against oxidative stress: Involvement of the transcription factor Nrf2 , 2005, Journal of neuroscience research.

[36]  B. Ames,et al.  Delaying the Mitochondrial Decay of Aging with Acetylcarnitine , 2004, Annals of the New York Academy of Sciences.

[37]  B. Ames,et al.  Comparison of the Effects of l‐Carnitine and Acetyl‐l‐Carnitine on Carnitine Levels, Ambulatory Activity, and Oxidative Stress Biomarkers in the Brain of Old Rats , 2004, Annals of the New York Academy of Sciences.

[38]  R. Bauer,et al.  Pathophysiology of traumatic injury in the developing brain: an introduction and short update. , 2004, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[39]  Larry R Squire,et al.  Spatial memory, recognition memory, and the hippocampus. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[40]  D. Hovda,et al.  Increased cerebral uptake and oxidation of exogenous βHB improves ATP following traumatic brain injury in adult rats , 2004, Journal of neurochemistry.

[41]  C. J. Van der Schyf,et al.  Acetyl-L-carnitine prevents total body hydroxyl free radical and uric acid production induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the rat. , 2004, Life sciences.

[42]  L. Massieu,et al.  Acetoacetate protects hippocampal neurons against glutamate-mediated neuronal damage during glycolysis inhibition , 2003, Neuroscience.

[43]  Y. Oomura,et al.  Effects of chronic acetyl-L-carnitine treatment on brain lipid hydroperoxide level and passive avoidance learning in senescence-accelerated mice , 2002, Neuroscience Letters.

[44]  V. Caso,et al.  The Action of Acetyl‐l‐Carnitine on the Neurotoxicity Evoked by Amyloid Fragments and Peroxide on Primary Rat Cortical Neurones , 2001, Annals of the New York Academy of Sciences.

[45]  S. Dunnett,et al.  Motor Coordination and Balance in Rodents , 2001, Current protocols in neuroscience.

[46]  G. Allen,et al.  Induction of heat shock proteins and motor function deficits after focal cerebellar injury , 2001, Neuroscience.

[47]  Michael B. Smith,et al.  Increased Plasma Beta-Hydroxybutyrate, Preserved Cerebral Energy Metabolism, and Amelioration of Brain Damage During Neonatal Hypoxia Ischemia with Dexamethasone Pretreatment , 2000, Pediatric Research.

[48]  T. Ishii,et al.  Anti-apoptotic effect of acetyl-l-carnitine and I-carnitine in primary cultured neurons. , 2000, Japanese journal of pharmacology.

[49]  P. Hof,et al.  Neuronal Subclass-Selective Loss of Pyruvate Dehydrogenase Immunoreactivity Following Canine Cardiac Arrest and Resuscitation , 2000, Experimental Neurology.

[50]  A. Faden,et al.  Effect of traumatic brain injury on mouse spatial and nonspatial learning in the Barnes circular maze. , 1998, Journal of neurotrauma.

[51]  A. Faden,et al.  Traumatic brain injury causes delayed motor and cognitive impairment in a mutant mouse strain known to exhibit delayed wallerian degeneration , 1998, Journal of neuroscience research.

[52]  G Fiskum,et al.  Neuroprotective effects of acetyl-L-carnitine after stroke in rats. , 1997, Annals of emergency medicine.

[53]  G. Fiskum,et al.  Effects of L-carnitine on serum triglyceride and cytokine levels in rat models of cachexia and septic shock. , 1995, British Journal of Cancer.

[54]  R. Rosenthal,et al.  Postischemic inhibition of cerebral cortex pyruvate dehydrogenase. , 1994, Free radical biology & medicine.

[55]  Filippo Conti,et al.  Effect of acetyl-l-carnitine on recovery of brain phosphorus metabolites and lactic acid level during reperfusion after cerebral ischemia in the rat — study by 13P- and 1H-NMR spectroscopy , 1994, Brain Research.

[56]  R. Rosenthal,et al.  Inhibition of postcardiac arrest brain protein oxidation by acetyl-L-carnitine. , 1993, Free radical biology & medicine.

[57]  J. Cavazos,et al.  Biochemical and behavioral effects of a sensorimotor cortex injury in rats pretreated with the noradrenergic neurotoxin DSP-4. , 1992, Behavioral neuroscience.

[58]  A. Ennaceur,et al.  A new one-trial test for neurobiological studies of memory in rats. III. Spatial vs. non-spatial working memory , 1992, Behavioural Brain Research.

[59]  R. Rosenthal,et al.  Prevention of Postischemic Canine Neurological Injury Through Potentiation of Brain Energy Metabolism by Acetyl‐L‐Carnitine , 1992, Stroke.

[60]  J. Pettegrew,et al.  Changes in Brain Energy and Phospholipid Metabolism During Development and Aging in the Fischer 344 Rat , 1990, Journal of neuropathology and experimental neurology.

[61]  J. Delacour,et al.  A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data , 1988, Behavioural Brain Research.

[62]  Lauren L. Jones,et al.  Acylcarnitines: role in brain. , 2010, Progress in lipid research.

[63]  J. LaManna,et al.  Effect of alternate energy substrates on mammalian brain metabolism during ischemic events. , 2008, Advances in experimental medicine and biology.

[64]  J. Muizelaar,et al.  Current concepts of cerebral oxygen transport and energy metabolism after severe traumatic brain injury. , 2007, Progress in brain research.

[65]  P. Mecocci,et al.  Pharmacokinetics of IV and oral acetyl-L-carnitine in a multiple dose regimen in patients with senile dementia of Alzheimer type , 2004, European Journal of Clinical Pharmacology.

[66]  R. Kanthan,et al.  Acetyl-L-carnitine attenuates neuronal damage in gerbils with transient forebrain ischemia only when given before the insult. , 1995, Neurochemical research.